Thromb Haemost 2001; 85(01): 190
DOI: 10.1055/s-0037-1612932
Letters to the Editor
Schattauer GmbH

Influence of Fluvastatin alone and in Combination Therapy on C Reactive Protein Levels in Patients with Coronary Artery Disease and Mixed Hyperlipidaemia (FACT Study)

M. Cortellaro
1   University of Milan, Italy
,
E. Cofrancesco
1   University of Milan, Italy
› Author Affiliations
the FACT Study Group
Further Information

Publication History

Received 21 September 2000

Accepted 30 September 2000

Publication Date:
08 December 2017 (online)

 

 
  • References

  • 1 Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. for the Cholesterol and Recurrent Events (CARE) investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999; 100: 230-5.
  • 2 Pauciullo P, Borgnino C, Paoletti R, Mariani M, Mancini M. on behalf of the FACT Study Centers. Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT Study). Atherosclerosis 2000; 150: 429-36.
  • 3 Cortellaro M, Cofrancesco E, Boschetti C, Cortellaro F, Mancini M, Mariani M, Paoletti R. on behalf of the Fact Study Centers. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT Study). Thromb Haemost 2000; 83: 549-53.